What is the Impact Factor of Anti-Cancer Agents in Medicinal Chemistry?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Anti-Cancer Agents in Medicinal Chemistry is 2.60, ranking in quartile Q3 of Web of Science (SCIE).

Is Anti-Cancer Agents in Medicinal Chemistry indexed in Web of Science or Scopus?

Yes, Anti-Cancer Agents in Medicinal Chemistry is indexed in Web of Science (SCIE, Q3 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.584 (Q3) and an H-index of 117.

Who publishes Anti-Cancer Agents in Medicinal Chemistry and what is the Article Processing Charge (APC)?

Anti-Cancer Agents in Medicinal Chemistry is published by Bentham Science Publishers B.V.. The estimated Article Processing Charge (APC) is approximately $2,925 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Anti-Cancer Agents in Medicinal Chemistry?

The official ISO-4 abbreviation of Anti-Cancer Agents in Medicinal Chemistry is "Anti-Cancer Agents Med. Chem". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q3Scopus Q3SCImago #10,146Hybrid

Anti-Cancer Agents in Medicinal Chemistry

Abbreviation (ISO):Anti-Cancer Agents Med. Chem

•

Identifier (ISSN):1871-5206(Print)/1875-5992(Online)

•

Publisher:Bentham Science Publishers B.V.

Official Website Submission Portal Compare

Clarivate IF (2026)

2.6↓ -0.4

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Anti-Cancer Agents in Medicinal Chemistry

WoS Q3

Annual Impact Factor Metric

Current (2026):2.6

Scopus SJR & RankScopus Q3

0.584

#10,146

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

117

117 papers with at least that number of citations each

WoS: SCIE / JCRQ3

Self-Citation Rate3.8%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

231articles/year

3.83% Gold OA•63.41% Original Research

Aims & Scope

Formerly: Current Medicinal Chemistry - Anti-Cancer Agents. Anti-Cancer Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of anti-cancer agents. Each issue contains a series of timely in-depth reviews and guest edited issues written by leaders in the field covering a range of current topics in cancer medicinal chemistry. The journal only considers high quality research papers for publication. Anti-Cancer Agents in Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments in cancer drug discovery.

Topics Covered (Recognized by AI)

Biology92.7%Medicine88%Genetics87.7%Chemistry84.8%Biochemistry79.7%Internal medicine75.4%Cancer59.9%Cancer research48.3%Organic chemistry42.5%Pharmacology36.6%Apoptosis36%In vitro35%Gene34.6%Cell biology30.8%Cell culture27.4%Cell27.4%Physics26.7%Immunology23.5%Pathology23.4%Cancer cell21.4%

Primary Research Areas

Oncology Chemistry Medicinal

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

CHEMISTRY, MEDICINAL

Rank48/72

IndexSCIE

JCRSCIE2026

ONCOLOGY

Rank196/333

IndexSCIE

JCISCIE2026

CHEMISTRY, MEDICINAL

Rank45/72

IndexSCIE

JCISCIE2026

ONCOLOGY

Rank196/333

IndexSCIE

Category	Index	Rank	Quartile
CHEMISTRY, MEDICINAL	JCRSCIE	48/72	Q3
ONCOLOGY	JCRSCIE	196/333	Q3
CHEMISTRY, MEDICINAL	JCISCIE	45/72	Q3
ONCOLOGY	JCISCIE	196/333	Q3

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF2.6

Articles / Year159

Total Citations32

2025

IF3

Articles / Year166

Total Citations303

2024

IF2.6

Articles / Year134

Total Citations609

2023

IF2.8

Articles / Year164

Total Citations947

2022

IF2.527

Articles / Year240

Total Citations2,113

Year	Impact Factor	Articles / Year	Total Citations
2026	2.6	159	32
2025	3	166	303
2024	2.6	134	609
2023	2.8	164	947
2022	2.527	240	2,113
2021	2.505	326	3,664
2020	2.049	361	5,503
2019	2.18	233	3,930
2018	2.556	257	4,326
2017	—	171	4,223
2016	—	186	3,869
2015	—	182	4,215

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #10,146Scopus Q3SCImago Profile

Scopus Coverage:2006-2026

•

Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyPharmacology, Toxicology and Pharmaceutics

Scopus Citation Rank (SJR)Q3

0.584

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3

Citations / Doc (2 years)

2.76

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$2,925 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations2,011

3-Year Documents612

Citable Documents588

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate45.2%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Cancer ResearchQ3

Molecular MedicineQ3

PharmacologyQ3

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 3.8%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

4区 (Zone 4)Medicine

Minor Category (Specific Field):

4区ONCOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Anti-Cancer Agents in Medicinal Chemistry (abbr: Anti-Cancer Agents Med. Chem, ISSN: 1871-5206) is a peer-reviewed international scholarly journal in the field of ONCOLOGY, published by Bentham Science Publishers B.V. in United Arab Emirates since 2006. The periodical holds a Journal Impact Factor (JIF) of 2.60, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.584 (Q3), an H-index of 117.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 231 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,925 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.